TY - JOUR
T1 - A case of aggressive systemic mastocytosis with bulky lymphadenopathy showing response to midostaurin
AU - Sciumè, Mariarita
AU - Serpenti, Fabio
AU - Muratori, Simona
AU - Pravettoni, Valerio
AU - Ulivieri, Fabio Massimo
AU - Croci, Giorgio Alberto
AU - Migliorini, Anna Chiara
AU - Esposito, Andrea
AU - Goldaniga, Maria Cecilia
AU - Saporiti, Giorgia Natascia
AU - Galassi, Giulia
AU - Baldini, Luca
AU - Onida, Francesco
AU - Grifoni, Federica Irene
N1 - Funding Information:
The authors thank the clinicians and nurses of our Institution who followed the patient and provided the data. Published with written consent of the patient.
Publisher Copyright:
© 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/2
Y1 - 2021/2
N2 - Management of systemic mastocytosis is an emerging challenge which requires a multidisciplinary diagnostic approach and personalized treatment strategy. Midostaurin can rapidly reduce the disease burden, also in cladribine refractory cases.
AB - Management of systemic mastocytosis is an emerging challenge which requires a multidisciplinary diagnostic approach and personalized treatment strategy. Midostaurin can rapidly reduce the disease burden, also in cladribine refractory cases.
KW - bulky lymphadenopathy
KW - midostaurin
KW - purine analogue
KW - systemic mastocytosis
UR - http://www.scopus.com/inward/record.url?scp=85098111765&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85098111765&partnerID=8YFLogxK
U2 - 10.1002/ccr3.3717
DO - 10.1002/ccr3.3717
M3 - Article
AN - SCOPUS:85098111765
VL - 9
SP - 978
EP - 982
JO - Clinical Case Reports
JF - Clinical Case Reports
SN - 2050-0904
IS - 2
ER -